/Novartis' Jakavi turns out positive PhIII results in PV; 'Are you prepared for anaphylaxis?' Adrian Peterson asks;
NEWS

Novartis' Jakavi turns out positive PhIII results in PV; 'Are you prepared for anaphylaxis?' Adrian Peterson asks;

FiercePharma
2014/06/04

Phase III data show polycythemia vera patients on Novartis' ($NVS) Jakavi achieved significant improvement in disease control. Release

Johnson & Johnson ($JNJ) has shifted its U.S. media buying account to OMD, part of the Omnicom Media Group division of the Omnicom Group. More (sub. req.)

AbbVie ($ABBV), Astellas and Roche ($RHHBY) have been nominated for the Pegasus Award for In-House Team of the Year at Communiqué. More

Brand experience agency SSG Create has secured Botox-maker Allergan ($AGN) as a client. Report

IDEA Pharma has appointed UPenn research specialist Rick Ritacco to its New York practice. Release

Jack Morton Worldwide has opened an office in Düsseldorf, Germany, following client wins with Novartis ($NVS) and Merck Serono. More

Johnson & Johnson ($JNJ), a World Cup sponsor through its Listerine and Regaine brands, has helped fuel growth at sponsorship agency Prism. More

And Finally... EpiPen maker Mylan ($MYL) and NFL star Adrian Peterson are calling on Americans to learn to be aware and prepared for anaphylaxis. Release

Summary

> Phase III data show polycythemia vera patients on Novartis' (NVS) Jakavi achieved significant improvement in disease control. Release > Johnson & Johnson (JNJ) has shifted its U.S....